Melatonin, sleep disturbance and cancer risk

Sleep Medicine Reviews

Volumn 13, Issue 4, 2009, Pages 257-264

  Blask, David E ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biological rhythms; Cancer risk; Circadian disruption; Cytokines; Immune function; Light at night; Melatonin; Night shift work; Pineal gland; Sleep disturbance

Indexed keywords

MELATONIN;

BREAST CANCER; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CIRCADIAN RHYTHM; CYTOKINE PRODUCTION; HIGH RISK POPULATION; HORMONE RELEASE; HUMAN; IMMUNE DEFICIENCY; LIGHT DARK CYCLE; PINEAL BODY; REVIEW; SHIFT WORKER; SLEEP DISORDER; SLEEP TIME; SLEEP WAKING CYCLE; SUNLIGHT;

ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; CIRCADIAN RHYTHM; DIETARY FATS; FEMALE; HUMANS; IMMUNE TOLERANCE; LINOLEIC ACID; MALE; MELATONIN; MICE; NEOPLASMS; PINEAL GLAND; SLEEP; SLEEP DISORDERS, CIRCADIAN RHYTHM; SUPRACHIASMATIC NUCLEUS; YOUNG ADULT;

EID: 67449103230     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2008.07.007     Document Type: Review

References (71)

1. Siegel J.M. Clues to the functions of mammalian sleep. Nature 437 (2005) 1264-1271
2. Pittendrigh C.S. Temporal organization: reflections of Darwinian clock-watcher. Ann Rev Physiol 55 (1993) 16-54
3. Stevens R.G., and Rea M.S. Light in the built-in environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control 12 (2001) 279-287
4. Stevens R.G., Blask D.E., Brainard G.C., Hansen J., Lockely S.W., Provencio I., et al. Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect 115 (2007) 1357-1362
5. Rajaratnam S.A., and Arendt J. Health in a 24-h society. Lancet 358 (2001) 999-1005
6. Sigurdson K., and Ayas N. The public health and safety consequences of sleep disorders. Canadian J Physiol Pharmacol 85 (2007) 179-183
7. Hublin C., Partinen M., Koskenvuo M., and Kapiro J. Sleep and mortality: a population-based 22-year follow-up study. Sleep 30 (2007) 1245-1253
8. Costa G. The impact of shift and night work on health. Appl Ergon 27 (1996) 9-16
9. Knutsson A. Health disorders of shift workers. Occup Med 53 (2003) 103-106
10. Dumont M., Haberou-Brun D., and Paquet J. Profile of 24-h light exposure and circadian phase of melatonin secretion in night workers. J Biol Rhythms 16 (2001) 502-511
11. Burch J.B., Yost M.G., Johnson W., and Allen E. Melatonin, sleep, and shift work adaptation. J Occup Environ Med 47 (2005) 893-901
12. Hansen J. Increased breast cancer among women who work predominantly at night. Epidemiology 12 (2002) 74-77
13. Davis S., Mirick D.K., and Stevens R.G. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93 (2001) 1557-1562
14. Schernhammer E.S., Laden F., Speizer F.E., Willet W.C., Hunter D.J., Kawachi I., et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 93 (2001) 1563-1568
15. Schernhammer E.S., Kroenke C.H., Laden F., and Hankinson S.E. Night work and risk of breast cancer. Epidemiology 17 (2006) 108-111
16. Schernhammer E.S., Laden F., Speizer F.E., Willet W.C., and Hunter D.J. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 95 (2003) 825-828
17. Kubo T., Ozasa K., Mikami K., Wakai K., and Fujino Y. Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. Am J Epidemiol 164 (2006) 549-555
18. Viswanathan A.N., Hankinson S.E., and Schernhammer E.S. Night shift work and the risk of endometrial cancer. Cancer Res 67 (2007) 10618-10622
19. Arendt J. Melatonin and human rhythms. Chronoiol Int 23 (2006) 21-37
20. In: Reiter R.J. (Ed). Melatonin. Endocrine 27 (2005) 87-212
21. Reiter R.J. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 79 (1991) 153-158
22. In: Reiter R.J. (Ed). Melatonin: medicinal chemistry and therapeutic potential. Curr Top Med Chem 2 (2002) 113-209
23. Brainard G.C., and Hanifin J.P. Photons, clocks, and consciousness. J Biol Rhythms 20 (2005) 314-325
24. Pandi-Perumal S.R., Srinivasan V., Maestroni G.J.M., Cardinali D.P., Poeggeler B., and Hardeland R. Melatonin: nature's most versatile biological signal?. FEBS J 273 (2006) 2813-2838
25. Blask D.E. Melatonin. McGraw-Hill yearbook of science and technology (2007), McGraw-Hill, New York 142-4
26. Akerstedt T., Froberg J.E., Friberg Y., and Wetterberg L. Melatonin excretion, body temperature and subjective arousal during 64 hours of sleep deprivation. Psychoneuroendocrinology 4 (1979) 219-225
27. Wehr T.A., Aeschbach D., and Duncan Jr. W.C. Evidence for a biological dawn and dusk in the human circadian timing system. J Physiol 535 (2001) 937-951
28. Strogatz S.H.R., Kronauer R.E., and Czeisler C.A. Circadian pacemaker interferes with sleep onset at specific times each day: role in insomnia. Am J Physiol 253 (1987) R172-R178
29. Lavie P. Ultrashort sleep-wake schedule. III: 'gates' and forbidden zones' for sleep. Electroencephalogr Clin Neurophysiol 63 (1986) 414-425
30. Lavie P., and Zvuluni A. The 24-hour sleep propensity function: experimental bases for somnotypology. Psychophysiology 29 (1992) 566-575
31. Shochat T., Luboshitzky R., and Lavie P. Nocturnal melatonin onset is phase locked to the primary sleep gate. Am J Physiol 273 (1997) R364-R370
32. Dijk D.J., Shanahan T.L., Duffy J.F., Ronda J.M., and Czeisler C.A. Variation of electroencephalographic activity during non-rapid eye movement and rapid eye movement sleep with phase of circadian melatonin rhythm in humans. J Physiol 505 (1997) 851-858
33. Aesbach D., Sher L., Postolache T.T., Matthews J.R., Jackson M.A., and Wehr T.A. A longer biological night in long sleepers than in short sleepers. J Clin Endocrinol Metab 88 (2003) 26-30
34. Wehr T.A. In short photoperiods, human sleep is biphasic. J Sleep Res 1 (1992) 103-107
35. Barbato G., Barker C., Bender C., Giesen H.A., and Wehr T.A. Extended sleep in humans in 14 hour nights (LD10:14): relationship between REM density and spontaneous awakening. Electroencephalogr Clin Neurophysiol 90 (1994) 291-292
36. Wehr T.A. The impact of changes in nightlength (scotoperiod) on human sleep. In: Turek F.W., and Zee P.C. (Eds). Regulation of sleep and circadian rhythms (1999), Marcel Dekker, New York 263-285
37. Ekirch A.R. At day's close: night in times past (2005), WW Norton, New York
38. Blask D.E., Sauer L.A., and Dauchy R.T. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem 2 (2002) 113-132
39. Blask D.E., Dauchy R.T., and Sauer L.A. Putting cancer to sleep at night - the neuroendocrine/circadian melatonin signal. Endocrine 27 (2005) 179-188
40. Reiter R.J. Mechanisms of cancer inhibition by melatonin. J Pineal Res 37 (2004) 213-214
41. Sauer L.A., Dauchy R.T., and Blask D.E. Polyunsaturated fatty acids, melatonin, and cancer prevention. Biochem Pharmacol 61 (2001) 1455-1462
42. Ram P.T., Dai J., Yuan L., Dong C., Kiefer T.L., Lai L., et al. Involvement of the mt1 melatonin receptor in human breast cancer. Cancer Lett 179 (2002) 141-150
43. Blask D.E., Brainard G.C., Dauchy R.T., Hanifin J.P., Davidson L.K., Krause J.A., et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 65 (2005) 11174-11184
44. Stevens R.G., and London S.J. Breast cancer. In: Stevens R.G. (Ed). The melatonin hypothesis - breast cancer and the use of electric power (1997), Battelle Press, Columbus, OH 9-24
45. Stevens R.G. Electric power use and breast cancer: a hypothesis. Am J Epidemiol 125 (1987) 556-561
46. Kloog I., Haim A., Stevens R.G., Barchana M., and Portnov B.A. Light at night co-distributes with incident breast but not lung cancer in the female population of Israel. Chronobiol Intl 25 (2008) 65-81
47. Lennernas M., Akerstedt T., and Hambraeus L. Nocturnal eating and serum cholesterol of three-shift workers. Scand J Work Environ Health 20 (1994) 401-406
48. Holmback U., Forslund A., Forslund J., Hambraeus L., Lenneras M., Lowden A., et al. Metabolic responses to nocturnal eating in men are affected by sources of dietary energy. J Nutr 132 (2002) 1892-1899
49. Schernhammer E.S., and Hankinson S.E. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 97 (2005) 1084-1087
50. Schernhammer E.S., Berrino F., Krogh V., Secreto G., Micheli A., Venturelli E., et al. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 100 (2008) 898-905
51. Tamarkin L., Danforth D., Lichter A., DeMoss E., Cohen M., Chabner B., et al. Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. Science 216 (1982) 1003-1005
52. Maestroni G.J.M., and Conti A. Melatonin in human breast cancer tissue: association with nuclear grade and estrogen receptor status. Lab Invest 75 (1996) 557-561
53. Smyth M.J., Dunn G.P., and Schrieber R.D. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 90 (2006) 1-50
54. Carrillo-Vico A., Guerrero J.M., Lardone P.J., and Reiter R.J. A review of the multiple actions of melatonin on the immune system. Endocrine 27 (2005) 189-200
55. Carrillo-Vico A., Reiter R.J., Lardone P.J., Herrera J.L., Fernandez-Montesinos R., Guerrero J.M., et al. The modulatory role of melatonin on immune responsiveness. Curr Opinion Invest Drugs 7 (2006) 423-431
56. Lucey D.R., Clerici M., and Shearer G.M. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 9 (1996) 532-562
57. Mocelin S., Marincola F.M., and Young H.A. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol 78 (2005) 1043-1051
58. Koo A.S., Armstrong C., Bochner B., Shimabukuro T., and Tso C. Interleukin-6 and renal cell cancer: production, regulation, and growth effects. Cancer Immunol Immunother 35 (1992) 97-105
59. Petrovsky N. Towards a unified model of neuroendocrine-immune interaction. Immunol Cell Biol 79 (2001) 350-357
60. Dimitrov S., Lang T., Tieken S., Fehm H.L., and Born J. Sleep associated regulation of T helper 1/T helper 2 cytokine balance in humans. Brain Behav Immun 18 (2004) 341-348
61. Krueger J.M., Fang J., Hansen M.K., Zhang J., and Obal Jr. F. Humoral regulation of sleep. News Physiol Sci 13 (1998) 189-194
62. Roscoe J.A., Kaufman M.E., Matteson-Rusby S.E., Palesh O.G., Ryan J.L., Kohli S., et al. Cancer-related fatigue and sleep disorders. The Oncologist 12 (2007) 35-42
63. Verkasalo P.K., Lillberg K., Stevens R.G., Hublin C., Partinen M., Koskenvuo M., et al. Sleep duration and breast cancer: a prospective cohort study. Cancer Res 65 (2005) 9595-9600
64. Wu A.H., Wang R., Koh W.P., Stanczyk F.Z., Lee H.P., and Yu M.C. Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis (2008 April 30) epub
65. Ferrie J.E., Shipley M.J., Cappuccio F.P., Brunner E., Miller M.A., Kumari M., et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep 30 (2007) 1659-1666
66. Pinheiro S.P., Schernhammer E.S., Tworoger S.S., and Michels K.B. A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 66 (2006) 5521-5525
67. McElroy J.A., Newcomb P.A., Titus-Ernstoff L., Trentham-Dietz A., Hampton J.M., and Egan K.M. Duration of sleep and breast cancer risk in a large population-based case control study. J Sleep Res 15 (2006) 241-249
68. Newby J.A., and Howard V. Environmental influences in cancer development. J Nutr Environ Med (2006) 1-59
69. Straif K., Baan R., Grosse Y., Secretan B., El Ghissassi F., Bouvard V., et al. Carcinogenicity of shift-work, painting and fire-fighting. Lancet Oncol 8 (2007) 1065-1066
70. Filipski E.L., Li X.M., and Lévi F. Disruption of circadian coordination and malignant growth. Cancer Causes Control 17 (2006) 509-514
71. Hrushesky W.J.M. The temporal organization of life: the impact of multifrequency non-linear biological time structure upon the host-cancer balance. Jpn J Clin Oncol 30 (2000) 529-533